Literature DB >> 8334640

Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas.

C J Hayostek1, E G Shaw, B Scheithauer, J R O'Fallon, T L Weiland, P J Schomberg, P J Kelly, T C Hu.   

Abstract

BACKGROUND: The majority of patients with astrocytomas of the cerebellum have an excellent prognosis; however, a small percentage of patients continue to do poorly. To clarify the clinical, pathologic, and treatment characteristics that determine prognosis and therapeutic recommendations, a large group of patients with astrocytic tumors of the cerebellum was reviewed and analyzed.
METHODS: A clinicopathologic analysis was performed of all patients undergoing initial operation for astrocytomas in the cerebellum between 1960 and 1984. Of the 132 patients, 105 patients had pilocytic astrocytomas and 27 had diffuse astrocytomas.
RESULTS: Multivariate analysis revealed that the division of pilocytic and diffuse histologic type was the most significant prognostic factor influencing survival. The 5-year, 10-year, and 20-year survival rates were 85%, 81%, and 79%, respectively, for patients with pilocytic astrocytomas and 7%, 7%, and 7%, respectively, for patients with diffuse astrocytomas (P < 0.001). Pilocytic astrocytomas occurred in a younger age group and were more commonly cystic and completely resected.
CONCLUSIONS: Astrocytomas of the cerebellum can be divided into two principal groups, the pilocytic and the diffuse astrocytomas, each of which has distinct clinical, pathologic, and prognostic characteristics.

Entities:  

Mesh:

Year:  1993        PMID: 8334640     DOI: 10.1002/1097-0142(19930801)72:3<856::aid-cncr2820720335>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Stereotactic radiation therapy for progressive residual pilocytic astrocytomas.

Authors:  Karlo J Lizarraga; Alessandra Gorgulho; Steve P Lee; Glenn Rauscher; Michael T Selch; Antonio A F DeSalles
Journal:  J Neurooncol       Date:  2012-05-27       Impact factor: 4.130

2.  p53 protein in pediatric malignant astrocytomas: a study of 21 patients.

Authors:  M B Bhattacharjee; J M Bruner
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 3.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

Review 4.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

Review 5.  Glioblastoma of the cerebellum in children: report of five cases and review of the literature.

Authors:  Gaddum D Reddy; Anish N Sen; Akash J Patel; Robert J Bollo; Andrew Jea
Journal:  Childs Nerv Syst       Date:  2013-01-09       Impact factor: 1.475

6.  Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.

Authors:  Karl Roessler; Alexander Bertalanffy; Hussun Jezan; Achmed Ba-Ssalamah; Irene Slavc; Thomas Czech; Herbert Budka
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

7.  Outcome of children with low-grade cerebellar astrocytoma: long-term complications and quality of life.

Authors:  Tycho J Zuzak; Andrea Poretti; Barbara Drexel; Daniel Zehnder; Eugen Boltshauser; Michael A Grotzer
Journal:  Childs Nerv Syst       Date:  2008-08-09       Impact factor: 1.475

Review 8.  Cerebellar astrocytomas in children.

Authors:  J W Campbell; I F Pollack
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

10.  Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?

Authors:  Tine Bernhardtsen; Henning Laursen; Marie Bojsen-Møller; Flemming Gjerris
Journal:  Childs Nerv Syst       Date:  2003-09-30       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.